Entering the UK market I: Requirements and best practices for healthcare companies

As part of the Health3-2-1 project, we invite you to a UK market entry webinar where we will explore key trends, opportunities, and the business environment within this dynamic region.

Date: 17.10.2024
Time: 13.00-14.30 (Estonian time)

Whether you're a business leader, entrepreneur, or SME looking to expand into the UK, this session is designed to offer valuable insights tailored to the life sciences sectors (HealthTech, MedTech, BioTech, and Pharma). You’ll also hear a real-life case study from a company successfully navigating the UK market.

Agenda:

13:00 – Opening words
Welcoming remarks and introduction to the webinar.

13:10 – Overview of the UK market entry
An analysis of UK market entry, including economic indicators, growth sectors, and trends relevant to SMEs. Presenter: Andreas-Heiki Pant, UK Branch Trade Adviser of Enterprise Estonia.
Enterprise Estonia (EIS) is agency responsible for Innovation implementation, export growth, FDI and Tourism flow to Estonia. Heiki is Export Advisor in London and helps Estonian companies to enter the UK market, identify the right supply chains and connect with relevant companies or organisations.

13:30 – Sector-specific insights into the UK market
Life Sciences Sector Overview for Healthcare Companies Entering London, UK.
Presenter: Wael Muselmani, Senior Investment Manager on Life Sciences, London & Partners

13:50 – Case study: company experience in the UK Market
A dive into UK market entry, featuring valuable experiences, best practices, and lessons learned from a company that has successfully navigated the process.
Presenter: Helena Ije, COO & Co-Founder at Better Medicine
Better Medicine leverages machine learning techniques to enhance radiological workflows and facilitate early disease detection. By automatically detecting, measuring, classifying, and tracking lesions on CT scans over time, Better Medicine allows radiologists to work more efficiently, improving both the speed and accuracy of their assessment.

14:15 – Q&A session
Open floor for questions from the audience to dive deeper into specific areas of interest or concern.
14:25 – Closing remarks

Health3-2-1 is an EU Interreg-funded project led by Tehnopol Science and Business Park (EE), Business Turku (FI), and Swecare (SE). The project aims to support small and medium-sized enterprises in the life sciences sector as they expand into export markets in the UK (London) and the US (Massachusetts or the Washington Metropolitan Area).

Selected companies will receive a comprehensive support package valued at up to €20,000, including tailored mentoring, thematic seminars, and up to two business missions to the target markets.

A limited number of companies will be selected to participate and receive support in reaching active sales.

The session will be recorded, and all registered participants will receive a copy after the event.

Valik

muuda

Registration

0.00

Tasuta

Kontaktid

muuda
Et saaksime vajadusel sinuga ostu asjus ühendust võtta.

Pilet #1


Makseviis

Teadus- ja ärilinnak Tehnopol

events@tehnopol.ee